Ian F. Tannock

Papers

Total Citations

H-Index

About

Ian F. Tannock is a pioneering oncologist and researcher whose work has fundamentally shaped our understanding of tumor biology and cancer therapy. His key research areas include tumor microcirculation, interstitial fluid pressure, and the barriers to effective drug delivery in solid tumors. Tannock’s major contributions center on elucidating how the abnormal tumor microenvironment—characterized by high interstitial fluid pressure and chaotic vasculature—impedes the accumulation of therapeutic agents, including liposomal drugs. His landmark 2015 study on the intra-tumoral relationship between microcirculation, interstitial fluid pressure, and liposome accumulation (74 citations) provided critical insights into why many cancer treatments fail to reach their targets, influencing the design of more effective nanomedicines. Beyond this, Tannock is widely recognized for his work on drug resistance, hypoxia, and the development of strategies to overcome physiological barriers in tumors. With a career spanning decades, he has authored over 200 publications and received numerous accolades, including the AACR Award for Outstanding Achievement in Cancer Research. His research continues to guide the rational design of cancer therapies, making him a foundational figure in translational oncology.